Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein
A Davidson, K Patora-Komisarska… - Nucleic acids …, 2011 - academic.oup.com
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein.
A Davidson, K Patora-Komisarska… - Nucleic Acids …, 2010 - europepmc.org
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
[PDF][PDF] Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein
A Davidson, K Patora-Komisarska… - Nucleic Acids …, 2011 - pdfs.semanticscholar.org
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
[PDF][PDF] Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein
A Davidson, K Patora-Komisarska, JA Robinson… - Nucleic Acids …, 2011 - core.ac.uk
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
[PDF][PDF] Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein
A Davidson, K Patora-Komisarska… - Nucleic Acids …, 2011 - academia.edu
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein
A Davidson, K Patora-Komisarska, JA Robinson… - Nucleic Acids …, 2011 - zora.uzh.ch
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
[PDF][PDF] Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein
A Davidson, K Patora-Komisarska, JA Robinson… - Nucleic Acids …, 2011 - Citeseer
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein
A Davidson, K Patora-Komisarska, JA Robinson… - Nucleic Acids …, 2011 - doc.rero.ch
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
[HTML][HTML] Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein
A Davidson, K Patora-Komisarska… - Nucleic Acids …, 2011 - ncbi.nlm.nih.gov
The pharmacological disruption of the interaction between the HIV Tat protein and its
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …
cognate transactivation response RNA (TAR) would generate novel anti-viral drugs with a …